What is the minimum investment required for PCD Pharma Franchise?

The minimum investment typically ranges from ₹2–5 lakhs, depending on territory size, product selection and initial stock planning. Our team will help structure this based on your goals.

What documents are required to become a franchise partner?

You will need a valid Drug License, GST registration and basic KYC documents. Our team will guide you through every step of the documentation process.

What kind of support and training do you provide?

We provide product training, sales guidance, marketing materials, doctor coverage strategies, and ongoing business support through dedicated account managers.

How are territories allocated and protected?

Territories are allocated based on mutual agreement and market mapping. We offer genuine monopoly rights with clear documentation to avoid internal competition.

What is the expected profit margin and ROI timeline?

Average profit margins range from 25–30%, with typical ROI timelines between 12–18 months, depending on your execution and territory potential.

How do you ensure product quality and compliance?

All products are manufactured in WHO-GMP certified facilities with 100% quality testing, robust documentation and DCGI approvals as applicable.

What is the delivery timeline and process?

Dispatch timelines depend on order size and location, but we maintain a strong track record of timely delivery across India with proper packaging and logistics partners.

Respiratory (cough/Cold)

Stelkof-ax

Ambroxol 15mg+ Guiaphensin 50mg + Terbutaline Sulphate. 1.25mg,Menthol 1mg

Pack: 100ML
Format: Shrink Pack

MRP₹79.69

A versatile triple-action respiratory formula designed for the effective management of productive coughs accompanied by bronchial congestion and airway narrowing. Stelkof-AX combines a potent bronchodilator with specialized mucolytic and expectorant agents to liquefy thick mucus and facilitate effortless breathing.

About The Product

Key Benefits

Targeteddd Bronchodilation with Terbutaline

Terbutaline Sulphate 1.25mg is a powerful beta-2 adrenergic agonist that works by relaxing the smooth muscles of the bronchial tubes. By rapidly widening the constricted airways, it provides relief from chest tightness and wheezing, ensuring better airflow and reduced respiratory effort during infections.

Advanced Mucolytic Action with Ambroxol

Ambroxol 15mg acts as a potent mucolytic agent that breaks down the chemical bonds of thick, sticky phlegm. It reduces the viscosity of the mucus and stimulates the production of natural pulmonary surfactants, making the secretions thinner and much easier for the body to mobilize and expel.

Effective Expectorant Support

Guaiphenesin 50mg is a trusted expectorant that increases the fluid volume of respiratory tract secretions. This "lubricating" effect reduces the stickiness of the mucus, transforming a painful, unproductive cough into a productive one that efficiently clears the lungs of trapped pathogens and debris.

Soothing Menthol Cooling Effect

Menthol 1mg provides an immediate cooling sensation to the irritated throat and upper respiratory tract. Its mild local anesthetic properties help soothe the raw sensation caused by persistent coughing, providing instant comfort while the active ingredients work on the lower respiratory system.

Synergistic Airway Clearance

The combination of ingredients in Stelkof-AX provides a comprehensive approach to chesty coughs. While the bronchodilator ensures the airways remain open, the mucolytic and expectorant components work together to liquefy and remove the underlying congestion, preventing the buildup of bacteria in stagnant mucus.

Enhanced Respiratory Comfort and Recovery

Stelkof-AX is specifically formulated for conditions where cough is complicated by thick mucus and airway resistance. By improving ventilation and clearing the bronchial tree, it helps the patient achieve better oxygenation and leads to a faster recovery from acute respiratory flare-ups.

Indication Productive Cough (Chesty Cough), Acute and Chronic Bronchitis, Bronchial Asthma with Congestion, Emphysema, Chronic Obstructive Pulmonary Disease (COPD), Upper Respiratory Infections with Thick Phlegm.

Indications

Productive Cough (Chesty Cough)
Acute and Chronic Bronchitis
Bronchial Asthma with Congestion
Emphysema
Chronic Obstructive Pulmonary Disease (COPD)
Upper Respiratory Infections with Thick Phlegm.

Product descriptions, dosage forms, and compositions listed on the website are for reference by licensed practitioners and distributors only.

Stelkof-ax